Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
US2023212686A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023212686-A1 |
| Application number | US-202217980974-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 4, 2022 |
| Priority date | Dec 31, 2021 |
| Publication date | Jul 6, 2023 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are a kit and a method for detecting target nucleic acids using magnetic nanoparticles. The kit for detecting target nucleic acids includes a reactor having an opening on one side and provided with a sample containing target nucleic acids, at least one magnetic nanoparticle part provided in the reactor, a conductive substrate provided to cover the opening of the reactor, and a magnetic field applying part for applying a magnetic field to the reactor, in which the magnetic nanoparticle part includes a magnetic nanoparticle including a core portion made of iron oxide and a shell portion made of gold and provided to surround the core portion, and a primer attached to the shell portion of the magnetic nanoparticle.
Opening claim text (preview).
What is claimed is: 1 . A kit for detecting target nucleic acids using magnetic nanoparticles comprising: a reactor having an opening on one side; at least one magnetic nanoparticle part provided in the reactor; a conductive substrate provided to cover the opening of the reactor; and a magnetic field applying part for applying a magnetic field to the reactor, wherein the magnetic nanoparticle part includes a magnetic nanoparticle including a core portion made of iron oxide and a shell portion made of gold and provided to surround the core portion, and a primer attached to the shell portion of the magnetic nanoparticle. 2 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein an average diameter of the magnetic nanoparticle is provided with a first length and an average thickness of the shell portion is provided with a second length, wherein the second length is 0.09 to 0.15 times greater than the first length. 3 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein an average diameter of the magnetic nanoparticle is provided with a first length and an average thickness of the shell portion is provided with a second length, wherein the first length is 170 nm to 300 nm and the second length is 15 nm to 40 nm. 4 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein the magnetic nanoparticle part is prepared by preparing a core portion made of iron oxide, providing a buffer portion containing silicon on the surface of the core portion, preparing magnetic nanoparticles by functionalizing an outer surface of the buffer portion with at least one of an amino group (—NH 2 ) and a thiol group (—SH) and forming a shell portion containing gold thereon, and mixing the magnetic nanoparticles and a thiolated reverse primer. 5 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein the primer includes a reverse primer, and further comprising an electrochemical signal measuring part for measuring an electrochemical signal using a first electrode, a second electrode, and a three-electrode module including the first electrode, the second electrode, and a conductive substrate, which are provided in the reactor. 6 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 5 , wherein the first electrode includes a reference electrode, the conductive substrate includes a working electrode, and the second electrode includes a counter electrode controlling an electron balance generated from the reference electrode and the working electrode, which are performed by a three-electrode module, the first or second electrode consists of any one or more of gold (Au), cobalt (Co), platinum (Pt), silver (Ag), carbon nanotube, graphene, and carbon, and the conductive substrate includes any one or more of indium tin oxide (ITO), ZnO, SnO 2 , In 2 O 3 , CdSnO 4 , a carbon substrate material including carbon nanotubes, a fluorine-doped tin oxide (FTO) added with fluorine, and an aluminum doped zinc oxide (AZO) added with aluminum. 7 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 6 , wherein the electrochemical signal measuring part includes any one or more of a differential pulse voltammeter (DPV), an anodic stripping voltammetry (ASV), a chronoamperometry (CA), a cyclic voltammetry, a square wave voltammetry (SWV), and an impedance meter. 8 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein the magnetic field applying part reversibly applies a magnetic field into the reactor one or more times with the conductive substrate interposed therebetween, and the magnetic field applying part moves the magnetic nanoparticle part toward the opening of the reactor and controls the degree of moving the magnetic nanoparticle part. 9 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein a sample containing the target nucleic acids includes any one or more of blood, serum, plasma, saliva, ascites, amniotic fluid, semen, lacrimal fluid, cerebrospinal fluid, bone marrow, pleural fluid, synovial fluid, lymph, urine, tissue biopsies and cell lines. 10 . The kit for detecting target nucleic acids using magnetic nanoparticles of claim 1 , wherein the target nucleic acid is cell free DNA (cfDNA) or circulating tumor DNA (ctDNA). 11 . A method for detecting target nucleic acids using magnetic nanoparticles comprising the steps of: preparing a magnetic nanoparticle part; obtaining a magnetic nanoparticle part with an amplified product collected on the surface by adding the magnetic nanoparticle part in a sample including target nucleic acids to perform polymerase chain reaction (PCR); adding the magnetic nanoparticle part with the amplified product collected on the surface in the reactor provided with an opening, covering the opening with a conductive substrate, and applying a magnetic field into the reaction from one side of the conductive substrate under a first condition; adding metal ions including any one or more of ruthenium (Ru), iron (Fe), silver (Ag), copper (Cu), nickel (Ni), cadmium (Cd) and zinc (Zn) into the reactor and then applying the magnetic filed under a second condition; and providing first and second electrodes in the reactor, and measuring an electrochemical signal using the first and second electrodes and the conductive substrate together. 12 . The method for detecting target nucleic acids using magnetic nanoparticles of claim 11 , wherein the preparing of the magnetic nanoparticle part comprises preparing a core portion made of iron oxide, providing a buffer portion including silicon on the surface of the core portion to prepare a pre-nanoparticle, preparing a magnetic nanoparticle by functionalizing an outer surface of the buffer portion with at least one of an amino group (—NH 2 ) and a thiol group (—SH) and forming a shell portion containing gold thereon, and mixing the magnetic nanoparticle and a primer and performing salt aging. 13 . The method for detecting target nucleic acids using magnetic nanoparticles of claim 12 , wherein an average diameter of the magnetic nanoparticle is provided with a first length and an average thickness of the shell portion is provided with a second length, wherein the first length is 170 nm to 300 nm and the second length is 15 nm to 40 nm. 14 . The method for detecting target nucleic acids using magnetic nanoparticles of claim 12 , wherein the preparing of the magnetic nanoparticle comprises impregnating the pre-nanoparticles in a solution containing an amine group and then sonicating the pre-nanoparticles at a temperature of 60° C. to 90° C. for 2 hours to 10 hours, washing the pre-nanoparticles using water after the sonication is completed and dispersing the washed pre-nanoparticles in water to prepare a pre-nanoparticle dispersion, and forming a shell portion by mixing gold nanoparticles and then adding a chloroauric acid (HAuCl 4 ) solution to prepare the pre-nanoparticle dispersion as magnetic nanoparticles, wherein the gold nanoparticles are prepared in advance in the form of particles having an average diameter of 0.5 nm to 5 nm and used as a seed. 15 . The method for detecting target nucleic acids using magnetic nanoparticles of claim 12 , wherein the primer includes a thiolated primer, and the salt aging includes adding and mixing the magnetic nanoparticles and the primers to a stirrer, and then adding a first solution and a second solution in a volume
Trapping microscopic beads · CPC title
Nucleic acid amplification reactions · CPC title
specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules · CPC title
Reagents, handling or storing thereof · CPC title
Electrodes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.